Trials / Withdrawn
WithdrawnNCT07116122
Evaluating a Wearable Tracking System for Family Caregivers of Persons With Dementia With Wandering Concerns
A Two-Stage Pilot Study to Evaluate the Feasibility (Stage I) and Efficacy (Stage II) of a Tracking System for Family Caregivers of Persons With Dementia
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This project has two stages feasibility (stage 1) and efficacy of the device (stage II) and is being completed to evaluate a tracking solution system (Care Companion) developed by Koronis Biomedical Technologies (KBT) to assist family caregivers of persons living with dementia that are at risk for wandering/elopement. Participants in this stage 1 will be involved in this project for approximately 1 month and stage II participants will be involved for approximately 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tracking/finding system | Persons living with Alzheimer's Disease or Related dementias will wear the Care Companion smartwatch for approximately one month (stage I) or 6 months (stage 2). The Caretakers will utilize the smart phone application (app) to monitor the person wearing the watch and be alerted to elopements. The system will notify a caregiver if the person with dementia leaves a defined area (e.g., the home) via the application. In the tether mode (e.g., outside of the home), the system monitors the distance between the smartwatch and the caregiver's smartphone. When a separation distance exceeds a set threshold, the application will alert the caregiver and start tracking the location of the person with dementia by displaying the person's position on the caregiver's smartphone. |
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2026-08-31
- Completion
- 2026-08-31
- First posted
- 2025-08-11
- Last updated
- 2026-02-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07116122. Inclusion in this directory is not an endorsement.